As reported (here) previously, the stem cell ALS therapy developed by Israel’s Kadimastem showed promise in the lab. Now, early results from human trials at Hadassah hospital in Jerusalem show that it has significantly slowed down disease progression without major side effects.

https://www.timesofisrael.com/early-clinical-trial-for-als-sufferers-shows-biotech-firm-on-the-right-track/